Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer
Top Cited Papers
- 12 April 2018
- journal article
- research article
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 378 (15), 1408-1418
- https://doi.org/10.1056/nejmoa1715546
Abstract
Apalutamide, a competitive inhibitor of the androgen receptor, is under development for the treatment of prostate cancer. We evaluated the efficacy of apalutamide in men with nonmetastatic castration-resistant prostate cancer who were at high risk for the development of metastasis.Keywords
Funding Information
- Janssen Research and Development
This publication has 13 references indexed in Scilit:
- Androgen Signaling in Prostate CancerCold Spring Harbor Perspectives in Medicine, 2017
- Phase 2 Study of the Safety and Antitumor Activity of Apalutamide (ARN-509), a Potent Androgen Receptor Antagonist, in the High-risk Nonmetastatic Castration-resistant Prostate Cancer CohortEuropean Urology, 2016
- Prevalence of Prostate Cancer Clinical States and Mortality in the United States: Estimates Using a Dynamic Progression ModelPLOS ONE, 2015
- Managing bone metastases and reducing skeletal related events in prostate cancerNature Reviews Clinical Oncology, 2014
- Denosumab and Bone Metastasis–Free Survival in Men With Nonmetastatic Castration-Resistant Prostate Cancer: Exploratory Analyses by Baseline Prostate-Specific Antigen Doubling TimeJournal of Clinical Oncology, 2013
- ARN-509: A Novel Antiandrogen for Prostate Cancer TreatmentCancer Research, 2012
- An update on androgen deprivation therapy for prostate cancerEndocrine-Related Cancer, 2010
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working GroupJournal of Clinical Oncology, 2008
- Natural History of Rising Serum Prostate-Specific Antigen in Men With Castrate Nonmetastatic Prostate CancerJournal of Clinical Oncology, 2005